Lauren Wilcoxen
COO & Head of Regulatory AffairsDr. Lauren Wilcoxen is COO & Head of Regulatory Affairs of CytoDyn Inc. from November 20, 2026. Dr. Wilcoxen has extensive experience in regulatory affairs, clinical development and biotechnology operations, including a track record of advancing oncology programs through key regulatory milestones. Over the past several years, Dr. Wilcoxen has provided regulatory consulting and operational support services to a variety of public and private biotechnology and pharmaceutical companies. From August 2026 to November 2026, she served as Senior Vice President, Regulatory Affairs of Xilio Therapeutics, Inc., a publicly traded clinical-stage biotechnology company. From June 2025 to August 2026, Dr. Wilcoxen provided independent regulatory consulting services to oncology biotechnology companies through Clarivance Bio, LLC. From May 2022 to October 2025, she served as Senior Vice President, Product Development and Regulatory Affairs of Checkpoint Therapeutics, Inc., which was a publicly traded clinical-stage biotechnology company until its acquisition by Sun Pharmaceutical Industries, Inc. From June 2020 to September 2022, she served as Vice President, Regulatory Affairs of Istari Oncology, Inc., a private clinical-stage biotechnology company. Dr. Wilcoxen serves on the board of directors of two cancer nonprofits, the American Cancer Society and Caring Community Foundation and was named one of the Top 50 Women Leaders in Healthcare by Women We Admire in January 2025. She also holds a Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professionals Society, a Ph.D. in microbiology and immunology from The University of North Carolina at Chapel Hill and a B.S. in biology from Mount Saint Mary’s University.
Positions
- Company NameCytoDyn Inc.Stock CodeCYDYPositionCOO & Head of Regulatory AffairsColleagues
- RERobert E. HoffmanCEO & Principal Accounting Officer
- TDTanya Durkee UrbachIndependent Chairman of the Board
- TBTyler BlokChief Legal Officer & Corporate Secretary
- JPJacob P. LalezariHead of Research and Translational Sciences
- RMRyan M. DunlapIndependent Director
- SMStephen M. SimesIndependent Director
- JBJonah B. SachaMember of Scientific Advisory Board
- HSHope S. RugoMember of Scientific Advisory Board
